In the case of PD-L1 expression, it has been noted that metastases present within the chest and around the primary tumour may have high expression rates, whereas distant metastases do not express PD-L1 at all, such as in the case of the brain secondary tumours rendering them insensitive to checkpoint inhibitor immunotherapy [11]. The gene discussed is CD274; the disease is neoplasm.